Photoactive TiO2 antibacterial coating on surgical external fxation pins for clinical application

International Journal of Nanomedicine

Volumn 10, Issue , 2015, Pages 3367-3375

  Villatte, Guillaume ^a,b   Massard, Christophe ^a   Descamps, StÉphane ^b   Sibaud, Yves ^a   Forestier, Christiane ^a   Awitor, Komla Oscar ^a  

^a UNIVERSITÉ CLERMONT AUVERGNE   (France)

^b UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

Author keywords

Antibacterial effect; External pin fxation; Hybrid sol gel; Mechanical strength; Titanium dioxide; Ultraviolet photoactivity

Indexed keywords

TITANIUM DIOXIDE; 2-NAPHTHOL ORANGE; ANTIINFECTIVE AGENT; AZO COMPOUND; BENZENESULFONIC ACID DERIVATIVE; BIOCOMPATIBLE COATED MATERIAL; TITANIUM;

ARTICLE; BACTERICIDAL ACTIVITY; CLINICAL PRACTICE; CONTROLLED STUDY; COW; EXTERNAL FIXATOR; INFECTION PREVENTION; MATERIAL COATING; NONHUMAN; PHOTOACTIVATION; PHOTOCATALYSIS; PHOTODEGRADATION; SCANNING ELECTRON MICROSCOPY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STRUCTURE ANALYSIS; SURFACE PROPERTY; ULTRAVIOLET IRRADIATION; X RAY ANALYSIS; X RAY DIFFRACTION; BONE NAIL; CHEMISTRY; DRUG EFFECTS; EQUIPMENT DESIGN; MATERIALS TESTING; MULTIDRUG RESISTANCE; PATHOGENICITY; PROCEDURES; STAPHYLOCOCCAL INFECTIONS; ULTRAVIOLET RADIATION;

BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

ANTI-BACTERIAL AGENTS; AZO COMPOUNDS; BENZENESULFONATES; BONE NAILS; COATED MATERIALS, BIOCOMPATIBLE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EQUIPMENT DESIGN; EXTERNAL FIXATORS; MATERIALS TESTING; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; TITANIUM; ULTRAVIOLET RAYS; X-RAY DIFFRACTION;

EID: 84929441369     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S81518     Document Type: Article

References (59)

1. Quintin J, Schuind F. Plus de trente ans d’utilisation du fxateur externe de Hoffmann® en Orthopédie-Traumatologie pédiatrique [Over thirty years of use of Hoffmann® external fxator in pediatric orthopedics-traumatology]. Rev Med Brux Nouv Ser. 2011;32(6):S46. French.
2. Schuind F. Technique de pose d’un fxateur externe unilatéral des membres [Technique for setting a unilateral external fxator members]. Techniques Chirurgicales Orthopédie-Traumatologie. 2012; 7(4):1–9. French.
3. Dell’Oca AF. External fxation. In: Ruedi TP, Murphy WM, editors. AO Principles of Fracture Management. Stuttgart, Germany: Georg Thieme Verlag; 2000.
4. Vincent JL. Nosocomial infections in adult intensive-care units. Lancet. 2003;361(9374):2068–2077.
5. Darouiche RO. Treatment of infections associated with surgical implants. N Engl J Med. 2004;350(14):1422–1429.
6. Jennison T, McNally M, Pandit H. Prevention of infection in external fxator pin sites. Acta Biomater. 2014;10(2):595–603.
7. Koseki H, Shida, Yoda, et al. Clinical and histomorphometrical study on titanium dioxide-coated external fxation pins. Int J Nanomedicine. 2013;8:593–599.
8. Green SA. Complications of external skeletal fxation. Clin Orthop. 1983; (180):109–116.
9. Parameswaran AD, Roberts CS, Seligson D, Voor M. Pin tract infection with contemporary external fxation: how much of a problem? J Orthop Trauma. 2003;17(7):503–507.
10. Ferreira N, Marais LC. Prevention and management of external fxator pin track sepsis. Strateg Trauma Limb Reconstr. 2012;7(2):67–72.
11. Zhao L, Chu PK, Zhang Y, Wu Z. Antibacterial coatings on titanium implants. J Biomed Mater Res B Appl Biomater. 2009;91(1): 470–480.
12. Checketts RG, MacEachem AG, Otterburn M. Pin track infection and the principles of pin site care. In: Bastiani GA, Apley G, Goldberg A, editors. Orthofx External Fixation in Trauma and Orthopaedics. London, UK: Springer; 2000.
13. Mahan J, Seligson D, Henry SL, Hynes P, Dobbins J. Factors in pin tract infections. Orthopedics. 1991;14(3):305–308.
14. Bajpai I, Basu B. Strategies to prevent bacterial adhesion on bioma-terials. In: Ramalingam M, Wang X, Chen G, Ma P, Cui FZ, editors. Biomimetics: Advancing Nanobiomaterials and Tissue Engineering. Hoboken, NJ, USA: John Wiley & Sons Inc; 2013.
15. Matsunaga T, Tomoda R, Nakajima T, Wake H. Photoelectrochemi-cal sterilization of microbial cells by semiconductor powders. FEMS Microbiol Lett. 1985;29(1–2):211–214.
16. Belapurkar AD, Sherkhane P, Kale SP. Disinfection of drinking water using photocatalytic technique. Curr Sci. 91(1):73–76.
17. Fujishima A, Honda K. Electrochemical photolysis of water at a semiconductor electrode. Nature. 1972;238(5358):37–38.
18. Fretwell R, Douglas P. An active, robust and transparent nanocrystalline anatase TiO2 thin flm preparation, characterisation and the kinetics of photodegradation of model pollutants. J Photochem Photobiol Chem. 2001;143(2):229–240.
19. Kangwansupamonkon W, Lauruengtana V, Surassmo S, Ruktanonchai U. Antibacterial effect of apatite-coated titanium dioxide for textiles applications. Nanomedicine. 2009;5(2):240–249.
20. Sunada K, Watanabe T, Hashimoto KJ. Studies on photokilling of bacteria on TiO2 thin flm. J Photochem Photobiol A. 2003;156:227–233.
21. Blake DM, Maness PC, Huang Z, Wolfrum EJ, Huang J. Application of the photocatalytic chemistry of titanium dioxide to disinfection and the killing of cancer cells. Sep Purif Methods. 1999;28(1):1–50.
22. Nonami T, Hase H, Funakoshi K. Apatite-coated titanium dioxide photocatalyst for air purification. Catal Today. 2004;96(3):113–118.
23. Sunda K, Kikuchi Y, Hashimoto K, Fujishima A. Bactericidal and detoxification effects of TiO2 thin flm photocatalysts. Environ Sci Technol. 1998;32:726–728.
24. Fujishima A, Rao TN, Tryk DA. Titanium dioxide photocatalysis. J Photochem Photobiol C. 2000;1(1):1–21.
25. Agarwal A, Weis TL, Schurr MJ, et al. Surfaces modifed with nanometer-thick silver-impregnated polymeric flms that kill bacteria but support growth of mammalian cells. Biomaterials. 2010;31(4):680–690.
26. Vasilev K, Sah V, Anselme K, et al. Tunable antibacterial coatings that support mammalian cell growth. Nano Lett. 2010;10(1):202–207.
27. Atiyeh BS, Costagliola M, Hayek SN, Dibo SA. Effect of silver on burn wound infection control and healing: review of the literature. Burns. 2007;33(2):139–148.
28. Li B, Liu X, Cao C, Dong Y, Ding C. Biological and antibacterial properties of plasma sprayed wollastonite/silver coatings. J Biomed Mater Res B Appl Biomater. 2009;91(2):596–603.
29. Necula BS, Fratila-Apachitei LE, Zaat SAJ, Apachitei I, Duszczyk J. In vitro antibacterial activity of porous TiO2-Ag composite layers against methicillin-resistant Staphylococcus aureus. Acta Biomater. 2009;5(9):3573–3580.
30. Chen X, Schluesener HJ. Nanosilver: a nanoproduct in medical application. Toxicol Lett. 2008;176(1):1–12.
31. Asharani PV, Lian Wu Y, Gong Z, Valiyaveettil S. Toxicity of silver nano-particles in zebrafsh models. Nanotechnology. 2008;19(25):255102.
32. Park EJ, Yi J, Kim Y, Choi K, Park K. Silver nanoparticles induce cytotoxicity by a Trojan-horse type mechanism. Toxicol In Vitro. 2010; 24(3):872–878.
33. Stolz A. Basic and applied aspects in the microbial degradation of azo dyes. Appl Microbiol Biotechnol. 2001;56(1–2):69–80.
34. Koseki H, Asahara T, Shida T, et al. Clinical and histomorphometrical study on titanium dioxide-coated external fxation pins. Int J Nanomedi-cine. 2013;8:593–599.
35. Haenle M, Fritsche A, Zietz C, et al. An extended spectrum bactericidal titanium dioxide (TiO2) coating for metallic implants In vitro effectiveness against MRSA and mechanical properties. J Mater Sci Mater Med. 2011;22(2):381–387.
36. Agence Française de Sécurité Sanitaire des Produits de Santé. [French Agency for the Safety of Health Products AFSSAPS. Titanium dioxide nanoparticles of zinc oxide in cosmetics: state of knowledge on skin penetration, genotoxicity and carcinogenesis. Paris, France: National Agency for the Safety of Medicines and Health Products.]; 2011. Available from: http://ansm.sante.fr/var/ansm_site/storage/original/application/af86f9684f0e2810a7cf1d5b0cefb0d5.pdf. Accessed: June 1, 2014. French.
37. Sayes CM, Wahi R, Kurian PA, et al. Correlating nanoscale titania structure with toxicity: a cytotoxicity and infammatory response study with human dermal fibroblasts and human lung epithelial cells. Toxicol Sci. 2006;92(1):174–185.
38. Yanagisawa R, Takano H, Inoue K, et al. Titanium dioxide nanoparticles aggravate atopic dermatitis-like skin lesions in NC/Nga mice. Exp Biol Med. 2009;234(3):314–322.
39. Landsiedel R, Ma-Hock L, Kroll A, et al. Testing metal-oxide nano-materials for human safety. Adv Mater. 2010;22(24):2601–2627.
40. Hajkova P, Spatenka P, Horsky J, Horska I, Kolouch A. Photocatalytic effect of TiO2 flms on viruses and bacteria. Plasma Process Polym. 2007;4(1):S397–S401.
41. Shiraish K, Koseki H, Tsurumoto T, et al. Antibacterial metal implant with a TiO2 – conferred photocatalytic bactericidal effect against Staphylococcus aureus. Surf Interface Anal. 2009;41(1):17–22.
42. Schoenfelder SM, Lange C, Eckart M, Hennig S, Kozytska S, Ziebuhr W. Success through diversity – how Staphylococcus epidermidis establishes as a nosocomial pathogen. Int J Med Microbiol. 2010; 300(6): 380–386.
43. Katsikogianni Missirlis YF. Concise review of mechanisms of bacterial adhesion to biomaterials and of techniques used in estimating bacteria-material interactions. Eur Cell Mater. 2004;8:37–57.
44. Rupp ME, Ulphani JS, Fey PD, Bartscht K, Mack D. Characterization of the importance of polysaccharide intercellular adhesin/hemagglutinin of Staphylococcus epidermidis in the pathogenesis of biomaterial-based infection in a mouse foreign body infection model. Infect Immun. 1999;67(5):2627–2632.
45. Jagger J. Near-UV radiation effects on microorganisms. Photochem Photobiol. 1981;34(6):761–768.
46. Markowska-Szczupak A, Ulfg K, Morawski A W. The application of titanium dioxide for deactivation of bioparticulates: an overview. Catal Today. 2011;169(1):249–257.
47. Žvab U, Lavrencˇicˇ Štangar U, Bergant Marušicˇ M. Methodologies for the analysis of antimicrobial effects of immobilized photocatalytic materials. Appl Microbiol Biotechnol. 2014;98(5):1925–1936.
48. Allahverdiyev AM, Abamor ES, Bagirova M, Rafailovich M. Antimicrobial effects of TiO(2) and Ag(2)O nanoparticles against drug-resistant bacteria and leishmania parasites. Future Microbiol. 2011;6(8):933–940.
49. Pelgrift RY, Friedman AJ. Nanotechnology as a therapeutic tool to combat microbial resistance. Adv Drug Deliv Rev. 2013;65(13–14):1803–1815.
50. Tsai TM, Chang HH, Chang KC, Liu YL, Tseng CC. A comparative study of the bactericidal effect of photocatalytic oxidation by TiO2 on antibiotic-resistant and antibiotic-sensitive bacteria. J Chem Technol Biotechnol. 2010;85(12):1642–1653.
51. Polo A, Diamanti MV, Bjarnsholt T, et al. Effects of photoactivated titanium dioxide nanopowders and coating on planktonic and bioflm growth of Pseudomonas aeruginosa. Photochem Photobiol. 2011;87(6): 1387–1394.
52. Rincon A. Effect of pH, inorganic ions, organic matter and H2O2 on E. coli K12 photocatalytic inactivation by TiO2: implications in solar water disinfection. Appl Catal B Environ. 2004;51(4):283–302.
53. Alrousan DMA, Dunlop PSM, McMurray TA, Byrne JA. Photocatalytic inactivation of E. coli in surface water using immobilised nanoparticle TiO2 flms. Water Res. 2009;43(1):47–54.
54. Foster HA, Sheel DW, Evans P, et al. Antimicrobial activity against hospital-related pathogens of dual layer CuO/TiO2 coatings prepared by CVD. Chemical Vapor Deposition. 2012;18(4–6):140–146.
55. Nir Baram DS. Photocatalytic inactivation of microorganisms using nanotubular TiO2. Appl Catal B Environ. 2011;101:212–219.
56. Ireland JC, Klostermann P, Rice EW, Clark RM. Inactivation of Escherichia coli by titanium dioxide photocatalytic oxidation. Appl Environ Microbiol. 1993;59(5):1668–1670.
57. Maness PC, Smolinski S, Blake DM, Huang Z, Wolfrum EJ, Jacoby WA. Bactericidal activity of photocatalytic TiO2 reaction: toward an understanding of its killing mechanism. Appl Environ Microbiol. 1999;65(9): 4094–4098.
58. Huang Z, Maness PC, Blake DM, Wolfrum EJ, Smolinski SL, Jacoby WA. Bactericidal mode of titanium dioxide photocatalysis. J Photochem Photobiol Chem. 2000;130(2):163–170.
59. Oliver JD. Recent fndings on the viable but nonculturable state in pathogenic bacteria. FEMS Microbiol Rev. 2010;34(4):415–425.